Abstract
The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors.
Keywords: Virtual screening, academic drug discovery, natural products, chemical diversity
Current Pharmaceutical Design
Title: The Drug Discovery Portal: A Computational Platform for Identifying Drug Leads from Academia
Volume: 16 Issue: 15
Author(s): Rachel L. Clark, Blair F. Johnston, Simon P. Mackay, Catherine J. Breslin, Murray N. Robertson, Oliver B. Sutcliffe, Mark J. Dufton and Alan L. Harvey
Affiliation:
Keywords: Virtual screening, academic drug discovery, natural products, chemical diversity
Abstract: The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors.
Export Options
About this article
Cite this article as:
L. Clark Rachel, F. Johnston Blair, P. Mackay Simon, J. Breslin Catherine, N. Robertson Murray, B. Sutcliffe Oliver, J. Dufton Mark and L. Harvey Alan, The Drug Discovery Portal: A Computational Platform for Identifying Drug Leads from Academia, Current Pharmaceutical Design 2010; 16 (15) . https://dx.doi.org/10.2174/138161210791164018
DOI https://dx.doi.org/10.2174/138161210791164018 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Origin of Lentivirus Research: Maedi-Visna Virus
Current HIV Research Recent Advances in Fluorescent Probes for Monitoring of Hydrogen Sulfide
Current Medicinal Chemistry Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System
CNS & Neurological Disorders - Drug Targets The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis
Current Pharmaceutical Design Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Chemical Constituents from the Chinese Bryophytes and Their Reversal of Fungal Resistance
Current Organic Chemistry MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1
Current Neurovascular Research Tamoxifen as a Powerful Neuroprotectant in Experimental Stroke and Implications for Human Stroke Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse
Current Neuropharmacology Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer’s Disease in Mouse Model
Current Medicinal Chemistry Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia
Current Topics in Medicinal Chemistry CD45 Regulated Signaling Pathways
Current Topics in Medicinal Chemistry Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Current Neuropharmacology Cation-Anion Ratios in Poultry Diets
Recent Patents on Food, Nutrition & Agriculture Glycation Induced Generation of Amyloid Fibril Structures by Glucose Metabolites
Protein & Peptide Letters Evaluation and Prediction of Early Alzheimer’s Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping
Current Alzheimer Research Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine
Drug Delivery Letters Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Current Vascular Pharmacology ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model
CNS & Neurological Disorders - Drug Targets